# US 2010/0168832 A1 · Scaffolds for artificial heart valves and vascular structures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168832 A1
- Document ID: US20100168832A1
- Status: Published application
- Kind: A1
- Application number: 12/303,897
- Filed: 2007-06-04
- Published: 2010-07-01
- Earliest claimed: 2006-06-09
- Assignees: Eidgenossische Technische Hochschule Zurich
- Inventors: Peter Neuenschwander
- Web page: https://patentgrep.com/patent/US20100168832A1

## CPC

- A61F 2/2415: {Manufacturing methods}
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3808: {Endothelial cells}
- A61L 27/3843: {Connective tissue}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- Y10T 442/10: Scrim [e.g., open net or mesh, gauze, loose or open weave or knit, etc.]
- Y10T 442/681: Spun-bonded nonwoven fabric
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention relates to scaffolds for artificial heart valves and vascular structures comprising a biocompatible block copolymer. A method and means for producing said scaffold are also provided.

## Claims

### Claim 1

Scaffold comprising an electro-spun mesh of a biocompatible block-copolymer, wherein said block copolymer has at least two block units obtainable by linear polycondensation in the presence of diisocyanate, diacid halide or phosgene of first block unit selected from the group consisting of a diol (I) and an α,ω-dihydroxy-polyester (IV) with a second block unit selected from the group consisting of the same diol (I), an α,ω-dihydroxy-polyester (II), an α,ω-dihydroxy-polyether (III), and the same α,ω-dihydroxy-polyester (IV),
wherein the diol (I) is obtainable by transesterification of poly-[(R)-(3)-hydroxybutyric acid] or copolymers thereof with 3-hydroxyvaleric acid with ethylene glycol,
wherein the α,ω-dihydroxy-polyester (II) is obtainable by ring-opening polymerization of cyclic esters selected from the group consisting of (L,L)-dilactide, (D,D)-dilactide, (D,L)-dilactide, diglycolide or mixtures thereof, or lactones selected from the group consisting of β-(R)-butyrolactone, β-(S)-butyrolactone, β-rac-butyrolactone and ε-caprolactone or mixtures thereof,
wherein the α,ω-dihydroxy-polyether (III) is selected from the group consisting of α,ω-dihydroxy-poly(oxytetramethylene), α,ω-dihydroxy-poly(oxyethylene) and copolymers of ethylene glycol and propylene glycol,
wherein the α,ω-dihydroxy-polyester (IV) is obtainable by trans-esterification of the diol (I) with diglycolide and/or dilactide and/or caprolactone or mixtures thereof.

### Claim 2 (depends on 1)

Scaffold according to claim 1, wherein the first block unit is the α,ω-dihydroxy-polyester (IV) and the second block unit is the diol (I).

### Claim 3 (depends on 1)

Scaffold according to claim 1, wherein the first block unit is the α,ω-dihydroxy-polyester (IV) and the second block unit is the α,ω-dihydroxy-polyester (II).

### Claim 4 (depends on 1)

Scaffold according to claim 1, wherein the first block unit is the α,ω-dihydroxy-polyester (IV) and the second block unit is the α,ω-dihydroxy-polyether (III).

### Claim 5 (depends on 1)

Scaffold according to claim 1, wherein the first block unit is the α,ω-dihydroxy-polyester (IV) and the second block unit is the same α,ω-dihydroxy-polyester (IV).

### Claim 6 (depends on 1)

Scaffold according to claim 1, wherein the scaffold is made of said block copolymer.

### Claim 7 (depends on 1)

Scaffold according to claim 1, wherein cells are cultured on said scaffold.

### Claim 8 (depends on 1)

Scaffold according to claim 1, wherein the scaffold has a tubular form.

### Claim 9 (depends on 1)

Scaffold according to claim 1, wherein the scaffold has a form of a vessel.

### Claim 10 (depends on 1)

Scaffold according to claim 1, wherein the scaffold has a form of a heart valve.

### Claim 11 (depends on 1)

Scaffold according to claim 1, wherein the scaffold is hydrolytically degradable and has a controllable service life time and keeps its performance from 5 days up to 2 years.

### Claim 12 (depends on 1)

A valve model (1) for producing the scaffold as claimed in claim 1, comprising at least two separate model parts (10, 20), wherein a first model part (10) has a cylindrical area (25) defining an axis (22) and, adjoining this area (25), a free end area (30) with at least two end faces (50), the cylindrical area (25), about its circumference, and the free end area (30) being intended to be coated with a polymer, and wherein a second model part (20) has a cylindrical portion (27) defining a further axis (22′), and, adjoining this portion (27), a free end portion (35) with at least two end faces (60) that are complementary to the end faces (50) of the first model part (10), the cylindrical portion (27) of the second model part (20) being intended to be coated about its circumference with a polymer.

### Claim 13 (depends on 12)

The valve model as claimed in claim 12, wherein the polymer-coated end faces (50) of the free end area (30) of the first model part (10) and the end faces (60) of the free end portion (35) of the second model part (20) can be brought into a position in which they lie opposite one another.

### Claim 14 (depends on 12)

The valve model as claimed in claim 12, wherein the valve model (1) is a heart valve model (101), the first model part (110) comprising four parts, namely a crown part (180) arranged securely on the cylindrical area (125) and three crown attachments (190), the crown part (180) and the three crown attachments (190) forming, in the free end area (130), three axially directed end faces (150), and, in the radial direction, three convex side faces (155) which adjoin the cylindrical area (125) and the end faces (150) and which are intended to be coated with a polymer, and the second model part (120) comprising four parts, namely a mating crown part (240) arranged securely on the cylindrical portion (127) and three mating crown attachments (250), which form, in the free end portion (135), three axially directed end faces (160), and, in the radial direction, three convex side faces (170) which adjoin the cylindrical portion (127) and the end faces (160) and which are intended to be coated with a polymer.

### Claim 15 (depends on 14)

The valve model as claimed in claim 14, wherein the end faces (150) in the free end area (130) of the first model part (110) are concave in the axial direction.

### Claim 16 (depends on 12)

The valve model as claimed in claim 12, wherein the valve model (1) is a vein valve model (301), the first model part (310) having a free end area (330) with only two end faces (350).

### Claim 17 (depends on 12)

The valve model (1) as claimed in claim 12, wherein the model comprises an electrically conductive material, preferably metal.

### Claim 18 (depends on 1)

Method for producing a scaffold for tissue engineering according to claim 1, comprising the steps
a) manufacturing a suitably formed carrier structure;
b) disposing a biocompatible polymer mesh on said carrier structure by electro-spinning; and
c) removing the carrier structure from the scaffold.

### Claim 19 (depends on 18)

Method according to claim 18, wherein the carrier structure is cooled by cooling means.

### Claim 20 (depends on 19)

Method according to claim 19, wherein the cooling means are cold gases, preferably nitrogen or CO2.

### Claim 21 (depends on 18)

Method according to claim 18, wherein the carrier structure has a tubular form.

### Claim 22 (depends on 18)

Method according to claim 18, wherein the carrier structure has a form of a vessel.

### Claim 23 (depends on 18)

Method according to claim 18, wherein the carrier structure has a form of a heart valve.

### Claim at position 24

24-25. (canceled)

### Claim 26 (depends on 7)

Scaffold according to claim 7, wherein said cells are selected from the group consisting of endothelial cells and myofibroblasts.

### Claim 27 (depends on 9)

Scaffold according to claim 9, wherein said scaffold has a form of a blood vessel.
